A detailed history of R. W. Roge & Company, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, R. W. Roge & Company, Inc. holds 553 shares of LLY stock, worth $440,005. This represents 0.26% of its overall portfolio holdings.

Number of Shares
553
Previous 550 0.55%
Holding current value
$440,005
Previous $497,000 1.61%
% of portfolio
0.26%
Previous 0.28%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$772.14 - $960.02 $2,316 - $2,880
3 Added 0.55%
553 $489,000
Q2 2023

Jul 14, 2023

BUY
$350.74 - $468.98 $192,907 - $257,939
550 New
550 $257,000
Q4 2022

Jan 30, 2023

BUY
$321.55 - $374.67 $176,852 - $206,068
550 New
550 $201,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track R. W. Roge & Company, Inc. Portfolio

Follow R. W. Roge & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of R. W. Roge & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on R. W. Roge & Company, Inc. with notifications on news.